Berberine Up-Regulates miR-340-5p to Protect Myocardial Ischaemia/Reperfusion from HMGB1-Mediated Inflammatory Injury
Authors:
Open Access
- 1 December 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 10 (2) , 931-942
Abstract
Aims: Myocardial ischaemia/reperfusion injury (MIRI) is a major cause of heart failure after myocardial infarction. Berberine (BBR) presents anti-inflammatory and immunosuppressive properties in many diseases. Our research looked into the therapeutic effects and mechanism of BBR in MIRI. Methods and results: MIRI animal and cell models were established. The mRNA and protein expressions were assessed using reverse transcription and quantitative real-time polymerase chain reaction and western blot. The haemodynamic parameters (left ventricular ejection fraction and left ventricular ejection fraction) were detected by echocardiography. The myocardial infarct size and myocardium lesion were assessed by triphenyltetrazolium chloride and haematoxylin–eosin staining. The levels of injury factors were determined by ELISA. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling staining was performed to analyse cell apoptosis. Dual luciferase reporter gene and RNA immunoprecipitation assays were carried out to verify the interaction between miR-340-5p and HMGB1. BBR administration could improve the haemodynamic parameters and infarct size in MIRI rats (all P < 0.05). In MIRI rat model, BBR reduced cardiomyocyte apoptosis and inflammation (all P < 0.05). BBR could promote miR-340-5p expression (0.64 ± 0.21, P < 0.05), which is lowly expressed in MIRI group (0.24 ± 0.10, P < 0.01) in compare with the sham group (0.99 ± 0.01). MiR-340-5p knockdown abolished the protective effects of BBR on H/R-treated cardiomyocytes (all P < 0.05). BBR suppressed the HMGB1/TLR4/NF-κB pathway activation in MIRI. HMGB1 functioned as the target of miR-340-5p, and its silencing reversed the effect of miR-340-5p inhibitor on BBR-treated MIRI. Conclusions: In MIRI, BBR repressed HMGB1-mediated TLR4/NF-κB signalling pathway through miR-340-5p to suppress cardiomyocyte apoptosis and inflammation.Keywords
Funding Information
- Youth Fund of Natural Science Foundation of Hunan Province (2020JJ5945)
- Natural Science Foundation of Hunan Province (2021JJ31111)
- Project of Turpan City Science and Technology Bureau (2019BJ002)
- Science and Technology Program of Hunan Province (2021JJ31111)
This publication has 37 references indexed in Scilit:
- Ischemia reperfusion injury, ischemic conditioning and diabetes mellitusJournal of Molecular and Cellular Cardiology, 2016
- Berberine Attenuates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation Response: Role of Silent Information Regulator 1Oxidative Medicine and Cellular Longevity, 2015
- Renalase Protects the Cardiomyocytes of Sprague-Dawley Rats Against Ischemia and Reperfusion Injury by Reducing Myocardial Cell Necrosis and ApoptosisKidney and Blood Pressure Research, 2015
- Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signalingApoptosis, 2015
- Protection of intravenous HMGB1 on myocardial ischemia reperfusion injuryInternational Journal of Cardiology, 2015
- HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-a and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2Journal of Innate Immunity, 2015
- HMGB1 in health and diseaseMolecular Aspects of Medicine, 2014
- Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in ratsNephrology, 2014
- HMGB1 and RAGE in Inflammation and CancerAnnual Review of Immunology, 2010
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007